Skip to main content
Premium Trial:

Request an Annual Quote

Taking on Reviews

SciWo says that she's reviewed about nine papers this year but in that same time she has only submitted one manuscript. "I know that reviews are a vital part of professional service, but I also know that I need to get another paper out this fall to keep me on pace for tenure. If reviews keep coming in at the same pace as they have this spring and fall, I know I won't get that paper finished up," she says.

She says there are three philosophies covering the number of reviews people accept: "more is better," "parity," and "bad compromise." "More is better" is unrealistic, she says, since her time is limited and "bad compromise," in which all reviews are accepted but only allotted a certain number of hours to be complete, is, well, bad. Instead, she wants to move toward "parity" in which she takes on about as many reviews as she has generated, but wonders if not accepting all reviews she's offered will backfire.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.